Annual report pursuant to Section 13 and 15(d)

ISSUANCE OF EQUITY INTERESTS (Details)

v3.22.4
ISSUANCE OF EQUITY INTERESTS (Details) - USD ($)
 12 Months Ended
Jul. 27, 2022
Jul. 25, 2022
Jun. 29, 2021
Jun. 23, 2021
Dec. 31, 2022
Dec. 31, 2021
Equity            
Common stock, Authorized (in shares)         200,000,000 200,000,000
Common stock, Outstanding (in shares)         11,627,609 10,215,792
Shares issued during the period   1,159,211 2,875,000      
Purchase price (in dollars per share)     $ 6.00      
Proceeds from Initial Public Offering, net of issuance costs     $ 14,800,000     $ 14,797,132
Cash issuance cost     $ 2,400,000   $ 529,805 $ 2,452,868
Converted shares of common stock     7,041,208 7,041,208    
Number of warrants     1,437,577      
Warrant exercise price (in dollars per share)     $ 2.88      
Common stock, par value   $ 0.001     $ 0.001 $ 0.001
Stock issue gross proceeds   $ 4,200,000 $ 17,300,000      
Proceeds from stock issue, net of costs   $ 3,700,000     $ 3,695,182  
Members' Equity, Class A and Class B            
Equity            
Converted to shares of common stock     14,082,318 14,082,318    
Series A warrants            
Equity            
Number of warrants   1,289,980        
Series B warrants            
Equity            
Number of warrants   1,289,980        
Affiliate Investors            
Equity            
Shares issued during the period   59,211        
Purchase price (in dollars per share)   $ 3.80        
Pre-funded Warrant Exercise (in shares)   130,769        
Affiliate Investors | Series A warrants            
Equity            
Number of warrants   59,211        
Warrant exercise price (in dollars per share)   $ 3.55        
Affiliate Investors | Series B warrants            
Equity            
Number of warrants   59,211        
Investor            
Equity            
Shares issued during the period   1,100,000        
Purchase price (in dollars per share)   $ 3.25        
Warrant exercise price (in dollars per share)   $ 0.0001        
Pre-funded Warrant Exercise (in shares)   130,769        
Purchase price pre-funded warrant (in dollars per share)   $ 3.2499        
Investor | Series A warrants            
Equity            
Number of warrants   1,230,769        
Investor | Series B warrants            
Equity            
Number of warrants   1,230,769        
Warrant exercise price (in dollars per share)   $ 3.25        
Underwriter            
Equity            
Number of warrants     150,000      
Warrant exercise price (in dollars per share)     $ 7.50      
Warrant exercisable term     4 years 6 months      
Registered direct offering            
Equity            
Shares issued during the period 1,159,211          
Pre-funded Warrant Exercise (in shares) 130,769          
Stock issue gross proceeds $ 4,200,000          
Placement Agents            
Equity            
Cash issuance cost   $ 287,874        
Number of warrants   63,018        
Warrant exercise price (in dollars per share)   $ 3.60        
Weighted average aggregate offering price (as a percent)   110.00%